Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EQUIGEN Single-Dose Study
NCT01733394Phase 4Completed
- Sponsor
- University of Cincinnati
- Start
- Dec 2012
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lamotrigine in epilepsy, sponsored by University of Cincinnati. Started Dec 2012; status: completed.
02
Drugs
lamotrigine
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT01733394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01733394.